Outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in a regional burns unit

L Teare1, O P Shelley, S Millership

  • 1Department of Microbiology, Broomfield Hospital, Chelmsford, Essex, UK. louise.teare@meht.nhs.uk

Insights

A Panton-Valentine leucocidin-producing methicillin-resistant Staphylococcus aureus (PVL-MRSA) outbreak on a burns unit was controlled by addressing staff carriage. This persistent infection spread across multiple stages and wards despite extensive cleaning efforts.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • A Panton-Valentine leucocidin-producing methicillin-resistant Staphylococcus aureus (PVL-MRSA) strain caused a prolonged outbreak over 16 months.
  • The specific PVL-MRSA strain was resistant to common antibiotics like ciprofloxacin, neomycin, and gentamicin.
  • This community-associated MRSA lineage was identified as circulating within the UK.

Purpose of the Study:

  • To investigate the epidemiology and control of a PVL-MRSA outbreak in a regional burns and plastics unit.
  • To identify the factors contributing to the persistence of the PVL-MRSA strain.
  • To determine the effective measures for controlling the spread of PVL-MRSA in a healthcare setting.

Main Methods:

  • Surveillance of colonization and infection over a 16-month period.
  • Implementation of stringent infection control measures, including unit closure and deep cleaning.
  • Investigation and management of staff carriage of the PVL-MRSA strain.

Main Results:

  • Thirty individuals (19 patients, 1 relative, 10 staff) were colonized or infected.
  • The outbreak progressed through four distinct stages, affecting different areas of the unit and a plastics ward.
  • Standard infection control measures, including deep cleaning, were insufficient to halt the outbreak's progression.
  • Control was ultimately achieved by addressing staff carriage of the PVL-MRSA strain.

Conclusions:

  • Staff carriage is a critical factor in the sustained transmission of PVL-MRSA within healthcare facilities.
  • Comprehensive strategies addressing both environmental and personnel factors are necessary for effective PVL-MRSA outbreak control.
  • The findings highlight the importance of vigilant surveillance and targeted interventions for resistant bacterial strains in clinical settings.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...